Nanotechnology : Western Australia

Centre for Strategic Nano-Fabrication ( CSNF )

Benj — Tue, 22 May 2007 11:15:41 +0000

Ticker Id

Web url

http://www.strategicnano.uwa.edu.au/

Contact Email

Short description

Street address

University of Western Australia, 35 Stirling Highway

Zip or postal code

6009

Telephone

+61 (08) 6488 3045

Fax

+61 (08) 6488 8683

Foundation date

Ceo, president

Number of employees

Long description

The core of CSNF is continuous flow processing technologies, e.g.: spinning disc processing (SDP) technology, which can deliver specific nano-particles of uniquely uniform size distribution. Applications of SDP technology are far reaching, in nano-medicine including drug delivery and imaging, and non-invasive treatment of cancers, nano-forensics through to applications in catalysis for fine chemicals synthesis, mineral processing, and other nano-material production. CSNF will address as core business nano-toxicology and the impact of nano-technology on the environment (sustainability metrics), making products attractive to industry, safe and acceptable to the community.

Additional Commentaries and remarks

Patents

Curtin University of Technology: Nanochemistry Research Institute

Benj — Fri, 25 Aug 2006 17:47:43 +0000

Ticker Id

Web url

http://nanochemistry.curtin.edu.au/

Contact Email

Short description

Street address

GPO Box U1987 Perth

Zip or postal code

6845

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

The Research Institute is the highest level of recognition of research excellence within Curtin University, and there are currently six operational. Both nanotechnology and biotechnology are highly topical areas, nationally and internationally, and nanochemistry forms a bridge between the two (ie, it spans physical and life sciences). During the past decade, Curtin has built the expertise and techniques in areas (such as crystallization and materials characterisation) that naturally lead into a substantial nanochemistry capability. It is thus timely to establish a Research Institute as a vehicle for focussing on strategic areas of research within nanochemistry in order both to enhance the reputation for research excellence, and also to bring the research to commercial fruition.

Additional Commentaries and remarks

Patents

pSivida Limited

Benj — Tue, 22 Aug 2006 12:46:13 +0000

Ticker Id

Web url

http://www.psivida.com.au/

Contact Email

pSivida@pSivida.com.au

Short description

Street address

Level 12 BGC Centre, 28 The Esplanade

Zip or postal code

6000

Telephone

(+61 8) 9226 5099

Fax

(+61 8) 9226 5499

Foundation date

Ceo, president

Gavin Rezos

Number of employees

Long description

pSivida shares were listed on the Australian Stock Exchange Limited on 1 December 2000. The company has approximately 102.8 million shares on issue.

The largest shareholder is the company's Managing Director, Mr Gavin Rezos, who holds 9.8%, Dr Roger Aston CEO pSiMedica / Director pSiVida has approximately 3% of the company.

Additional Commentaries and remarks

Patents

BioTech Capital, Ltd.

Benj — Fri, 18 Aug 2006 18:36:01 +0000

Ticker Id

Web url

http://www.biotechcapital.com.au/

Contact Email

Short description

Street address

Level 2, 55 St.Georges Tce

Zip or postal code

6000

Telephone

+61 8 9267 4788

Fax

+61 8 9267 4701

Foundation date

Ceo, president

Number of employees

Long description

The Company's investment plan is based on the general rationale of the PDF program, which is to encourage the provision of patient equity capital to small and medium sized Australian companies. The Company's investment objectives are to identify entities which are developing technology driven medical research for life-science and health-care applications. Our investment approach is geared towards the construction of a diversified portfolio of 10-20 companies across a spectrum of activities and stage of development.

We spend considerable effort in ensuring we remain fully informed of new areas of interest - particularly where Australia may have an existing competitive position or track record. Examples of this includes medical devices, diagnostics, immunology and stem cell biology.

Investors should appreciate that the life sciences industry is a rapidly evolving system where change is a constant and a technology that is competitive today may very well be a broadly available commodity tomorrow.

Additional Commentaries and remarks

Patents

Advanced Nanotechnology Limited (Advanced Nano)

Benj — Wed, 16 Aug 2006 20:20:09 +0000

Ticker Id

Web url

http://www.advancednanotechnology.com/

Contact Email

Short description

Street address

108 Radium St

Zip or postal code

6016

Telephone

+61 8 9458 0800

Fax

+61 8 9458 0810

Foundation date

Ceo, president

Number of employees

Long description

The vision of Advanced Nano is to become a world-class leader in the manufacture of nanopowders and nanopowder products. To achieve this goal we:

* manufacture products and provide services that consistently meet the needs and requirements of our customers
* involve all employees and customers as appropriate in continually improving the value of our products
* build strong partnerships with our customers and distributors, to enhance the quality of our products and hence the long term profitability and growth of Advanced Nano
* ensure compliance with all relevant quality standards and regulations through a highly motivated Quality team

Download PDFAdvanced Nano strives for continuous improvement and the highest quality in all facets of our activities. Our aim is to provide innovative products and services that excite our customers and exceed their expectations of quality, reliability and value.

Evidence of our commitment to quality performance is our registration to ISO 9001: 2000. The quality management system ensures consistent high quality products by identifying the needs of our customers and applicable regulatory requirements. Our goal is to produce quality guaranteed products that guarantee customer satisfaction through the diligent application of the quality system.